KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹7.87 Cr | ₹7.08 Cr | ₹6.27 Cr | ₹4.99 Cr | ₹1.45 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KOPRAN ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹7.87 Cr |
Mar2023 | ₹7.08 Cr |
Mar2022 | ₹6.27 Cr |
Mar2021 | ₹4.99 Cr |
Mar2020 | ₹1.45 Cr |
How is Deferred Tax Assets / Liabilities of KOPRAN Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7.87 Cr | 11.15 | |
Mar2023 | ₹7.08 Cr | 12.87 | |
Mar2022 | ₹6.27 Cr | 25.74 | |
Mar2021 | ₹4.99 Cr | 243.76 | |
Mar2020 | ₹1.45 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹772.3 Cr | 1% | -11.1% | -39.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 1% |
-11.1% |
-39.2% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses